DrugPatentWatch Database Preview
Drugs in Development Information for Nitrendipine
» See Plans and Pricing
What is the development status for investigational drug Nitrendipine?
Nitrendipine is an investigational drug.
There have been 8 clinical trials for Nitrendipine.
The most recent clinical trial was a Phase 3 trial, which was initiated on November 1st 2009.
The most common disease conditions in clinical trials are Hypertension, Coronavirus Infections, and Neoplasm Metastasis. The leading clinical trial sponsors are Haining Health-Coming Biotech Co., Ltd., West China Hospital, and Katholieke Universiteit Leuven.
Summary for Nitrendipine
| US Patents | 0 |
| International Patents | 0 |
| US Patent Applications | 1,772 |
| WIPO Patent Applications | 2,507 |
| Japanese Patent Applications | 4 |
| Clinical Trial Progress | Phase 3 (2009-11-01) |
| Vendors | 82 |
Recent Clinical Trials for Nitrendipine
| Title | Sponsor | Phase |
|---|---|---|
| Coronavirus ACE Inhibitor Investigation | National University of Ireland, Galway, Ireland | Phase 4 |
| Clinical Studies by Using Accelerated PDX Model to Screen Drugs for Advanced Solid Tumor | Haining Health-Coming Biotech Co., Ltd. | Phase 2 |
| Treatment of Hypertension in Tibetan Adult Population | West China Hospital | Phase 4 |
Clinical Trial Summary for Nitrendipine
Top disease conditions for Nitrendipine
Top clinical trial sponsors for Nitrendipine
US Patents for Nitrendipine
| Drugname | Patent Number | Patent Title | Patent Assignee | Estimated Expiration |
|---|---|---|---|---|
| >Drugname | >Patent Number | >Patent Title | >Patent Assignee | >Estimated Expiration |
